Rebecca Araujo

DocwireNews

A study published in <a href="https://www.nature.com/articles/s41467-021-22140-0">Nature Communications</a> compared whole-genome sequencing between multiple myeloma (MM) and two precursor conditions: <a href="https://www.docwirenews.com/hematology-oncology/pesticide-exposure-linked-to-multiple-myeloma-precursor/">monoclonal gammopathy of undetermined significance</a> (MGUS) or smoldering myeloma (SM).For this study, investigators from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine evaluated the whole genome sequence profile of 18 patients with MGUS and compared them to 14 patients with SM and 80 patients with MM. The team assessed a variety of genetic variations, including insertions, deletions, and driver gene mutations. Patients were followed for more than a year to monitor disease progression. The researchers found that patients with MGUS and a lighter mutational load were less likely to progress to MM.&ldquo;Most patients with MGUS will never progress, but some will,&rdquo; said Ola Landgren, MD, professor of medicine, chief of the Myeloma Service, and principal investigator (PI) of the Myeloma Genomic Laboratory at Sylvester, via <a href="https://www.newswise.com/articles/whole-genome-sequencing-offers-new-diagnostic-insights-for-multiple-myeloma-precursor-conditions?sc=sphr&amp;xy=10027672">press release</a>. &ldquo;Using modern genomic assays and analytical algorithms, we are able to split the older terminology of MGUS and define progressors versus non-progressors.&rdquo;Prior to this study, according to the authors, it was believed that disease progression for MM was linear from MGUS to SM to MM. The non-progressive, clinically stable precursor condition, which was identified in 15 patients, was marked by later initiation in the patient&rsquo;s life and the absence of certain myeloma-defining genomic events, such as chromothripsis, templated insertions, mutations in driver genes, aneuploidy, and canonical APOBEC mutational activity.&ldquo;The bigger picture is that there are several genomic defining events involved in the progression of MM,&rdquo; said Francesco Maura, MD, assistant professor and co-PI of the Myeloma Genomic Laboratory. &ldquo;So far, whole genome sequencing is the only technology that captures all these changes.&rdquo;

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Genomic Sequencing Provides Insight into Myeloma Precursors

Oncology

A study published in Nature Communications compared whole-genome sequencing between multiple myeloma (MM) and two precursor conditions: monoclonal gammopathy of undetermined ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe